BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cell Genesys, Inc. (Acquired by BioSante Pharmaceuticals, Inc.) 

500 Forbes Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-266-3000 Fax: 650-266-3010


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Biotherapeutics

Collaborations

Aventis Pharmaceuticals, Inc.  Licensing agreement for gene-activated erythropoietin (EPO)

Pharmacia & Upjohn (Merged to form Pharmacia Corp)  Vector-licensing agreement in the field of animal health

Becton, Dickinson and Company  Vector-licensing agreement in the field of genomics-based drug discovery

VectorLogics, Inc.  Research agreement in which Cell Genesys' oncolytic virus therapies will be evaluated in combination with novel methods to further enhance the viruses' cell targeting abilities.





 Company News
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Completion of Merger 10/14/2009 11:35:06 AM
BioSante Pharmaceuticals, Inc. (BPAX) And Cell Genesys, Inc. (CEGE) Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009 10/1/2009 10:44:21 AM
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Final Exchange Ratio for Merger 9/23/2009 8:56:01 AM
RiskMetrics – ISS Governance Services Recommends Stockholders Vote “FOR” BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Merger 9/17/2009 9:21:15 AM
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce September 30, 2009 Special Stockholders Meetings to Approve Merger 9/3/2009 9:55:36 AM
Cell Genesys, Inc. (CEGE) Announces Second Quarter 2009 Financial Results 8/5/2009 9:49:15 AM
BioSante Pharmaceuticals, Inc. (BPAX) to Buy Cell Genesys, Inc. (CEGE) for $38 Million 6/30/2009 7:54:27 AM
Cell Genesys, Inc. (CEGE) Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives 6/23/2009 9:42:37 AM
Cell Genesys, Inc. (CEGE) Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives; Company’s Staff Down to 9 6/23/2009 7:33:52 AM
Cell Genesys, Inc. (CEGE) Commences Exchange Offer for $68.3 million Convertible Notes 5/26/2009 9:17:07 AM
12345678910...